There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...] …
Articles by : Bella Czajkowski, National Correspondent
Pharmaceutical giant Amgen recently announced it will exempt Tennessee providers from its contract pharmacy restrictions despite a carve out in [...] …
SpecGx, a generic subsidiary of Mallinckrodt Pharmaceuticals, will refund 340B covered entities that purchased addiction treatment medication Methadose for above [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...] …
An Indiana congresswoman recently introduced a controversial U.S. House bill that could potentially require 340B covered entities to pass all [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...] …
Multiple hospital advocacy groups have filed an amicus brief urging a federal district judge to uphold Nebraska’s recently enacted 340B [...] …
Three drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in light of new contract [...] …